346
Views
3
CrossRef citations to date
0
Altmetric
Review

Molecular diagnosis of toxoplasmosis: recent advances and a look to the future

, , , &
Pages 1529-1542 | Received 31 Mar 2021, Accepted 08 Jun 2021, Published online: 21 Aug 2021

References

  • Nicolle C, Manceaux L. Sur un protozoaire nouveau du gondi. C R Seances Acad Sci. 1909;148:369–372.
  • Dubey JP. Toxoplasmosis of animals and humans. CRC Press; 2016.
  • Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39:1385–1394.
  • Rostami A, Riahi SM, Gamble HR, et al. Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis. Clin Microbiol Infect. 2020;26:673–683.
  • Montoya J, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965–1976.
  • Fernàndez-Sabé N, Cervera C, Fariñas MC, et al. Risk Factors, Clinical Features, and Outcomes of Toxoplasmosis in Solid-Organ Transplant Recipients: a Matched Case-Control Study. Clin Infect Dis. 2012;54:355–361.
  • Su C, Khan A, Zhou P, et al. Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages. PNAS. 2012;109:5844–5849.
  • Shwab EK, Zhu X-Q, Majumdar D, et al. Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping. Parasitology. 2014;141:453–461.
  • Robert-Gangneux F, Dardé M-L. Epidemiology of and Diagnostic Strategies for Toxoplasmosis. Clin Microbiol Rev. 2012;25:264–296.
  • Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in Southern Brazil. Am J Ophthalmol. 1992;114:136–144.
  • Carme B, Bissuel F, Ajzenberg D, et al. Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana. J Clin Microbiol. 2002;40:4037–4044.
  • Martino R, Maertens J, Bretagne S, et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis. 2000;31:1188–1194.
  • Dunn D, Wallon M, Peyron F, et al. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet. 1999;353:1829–1833.
  • Wallon M, Peyron F. Congenital toxoplasmosis: a plea for a neglected disease. Pathogens. 2018;7:25.
  • The SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet. 2007;369:115–122.
  • Wallon M, Liou C, Garner P, et al. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ. 1999;318:1511–1514.
  • Hotop A, Hlobil H, Groß U. Efficacy of rapid treatment initiation following primary toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2012;54:1545–1552.
  • Cortina-Borja M, Tan HK, Wallon M, et al. Prenatal Treatment for Serious Neurological Sequelae of Congenital Toxoplasmosis: an Observational Prospective Cohort Study. PLoS Med. 2010;7:e1000351.
  • Dard C, Fricker-Hidalgo H, Brenier-Pinchart M-P, et al. Relevance of and new developments in serology for toxoplasmosis. Trends Parasitol. 2016;32:492–506.
  • Burg JL, Grover CM, Pouletty P, et al. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol. 1989;27:1787–1792.
  • Murat J-B, Fricker Hidalgo H, Brenier-Pinchart M-P, et al. Human toxoplasmosis: which biological diagnostic tests are best suited to which clinical situations? Expert Rev Anti Infect Ther. 2013;11:943–956.
  • Villena I, Ancelle T, Delmas C, et al. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Eurosurveillance. 2010;15(25):19600. .
  • Prusa A-R, Kasper DC, Olischar M, et al. Evaluation of serological prenatal screening to detect Toxoplasma gondii infections in Austria. NEO. 2013;103:27–34.
  • Fanigliulo D, Marchi S, Montomoli E, et al. Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017. Parasite. 2020;27:2.
  • Peyron F, L’ollivier C, Mandelbrot L, et al. Maternal and congenital toxoplasmosis: diagnosis and treatment recommendations of a French multidisciplinary working group. Pathogens. 2019;8:24.
  • Hohlfeld P, Daffos F, Costa J-M, et al. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. NEJM. 1994;331:695–699.
  • Costa J-M, Ernault P, Gautier E, et al. Prenatal diagnosis of congenital toxoplasmosis by duplex real-time PCR using fluorescence resonance energy transfer hybridization probes. Prenat Diagn. 2001;21:85–88.
  • Romand S, Chosson M, Franck J, et al. Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii. Am J Obstet Gynecol. 2004;190:797–802.
  • Yamamoto L, Targa LS, Sumita LM, et al. Association of parasite load levels in amniotic fluid with clinical outcome in congenital toxoplasmosis. Obstet Gynecol. 2017;130:335–345.
  • Kaiser K, Van Loon AM, Pelloux H, et al. Multicenter proficiency study for detection of Toxoplasma gondii in amniotic fluid by nucleic acid amplification methods. Clin Chim Acta. 2007;375:99–103.
  • Sterkers Y, Pratlong F, Albaba S, et al. Novel Interpretation of molecular diagnosis of congenital toxoplasmosis according to gestational age at the time of maternal infection. J Clin Microbiol. 2012;50:3944–3951.
  • Wallon M, Franck J, Thulliez P, et al. Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid. Obstet Gynecol. 2010;115:727–733.
  • Teixeira LE, Kanunfre KA, Shimokawa PT, et al. The performance of four molecular methods for the laboratory diagnosis of congenital toxoplasmosis in amniotic fluid samples. Rev Soc Bras Med Trop. 2013;46:584–588.
  • Prusa A-R, Kasper DC, Pollak A, et al. Amniocentesis for the detection of congenital toxoplasmosis: results from the nationwide Austrian prenatal screening program. Clin Microbiol Infect. 2015;21:191.e1–191.e8.
  • de Oliveira Azevedo CT, do Brasil PE, Guida L, et al. Performance of polymerase chain reaction analysis of the amniotic fluid of pregnant women for diagnosis of congenital toxoplasmosis: a systematic review and meta-analysis. PLoS One. 2016;11:e0149938.
  • Tóth T, Sziller I, Papp Z. PCR detection of Toxoplasma gondii in human fetal tissues. In: Meltzer SJ, editor. PCR in Bioanalysis. Totowa, NJ: Humana Press; 1998.
  • Robert-Gangneux F, Dupretz P, Yvenou C, et al. Clinical relevance of placenta examination for the diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J. 2010;29:33–38.
  • Lebech M, Joynson DHM, Seitz HM, et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. Eur J Clin Microbiol Infect Dis. 1996;15:799–805.
  • Fricker-Hidalgo H, Brenier-Pinchart M-P, Schaal J-P, et al. Value of Toxoplasma gondii detection in one hundred thirty-three placentas for the diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J. 2007;26:845–846.
  • Filisetti D, Cocquerelle V, Pfaff A, et al. Placental testing for Toxoplasma gondii is not useful to diagnose congenital toxoplasmosis. Pediatr Infect Dis J. 2010;29:665–667.
  • Filisetti D, Yera H, Villard O, et al. Contribution of Neonatal Amniotic Fluid Testing to Diagnosis of Congenital Toxoplasmosis. J Clin Microbiol. 2015;53:1719–1721.
  • Peyron F, Mc Leod R, Ajzenberg D, et al. Congenital toxoplasmosis in France and the United States: one parasite, two diverging approaches. PLoS Negl Trop Dis. 2017;11(2):e0005222. .
  • Sterkers Y, Ribot J, Albaba S, et al. Diagnosis of congenital toxoplasmosis by polymerase chain reaction on neonatal peripheral blood. Diagn Microbiol Infect Dis. 2011;71:174–176.
  • Olariu TR, Remington JS, Montoya JG. Polymerase chain reaction in cerebrospinal fluid for the diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J. 2014;33:566–570.
  • Fuentes I, Rodriguez M, Domingo CJ, et al. Urine sample used for congenital toxoplasmosis diagnosis by PCR. J Clin Microbiol. 1996;34:2368–2371.
  • Loveridge-Easther C, Yardley AM, Breidenstein B. Use of polymerase chain reaction (PCR) in the diagnosis of congenital toxoplasmosis. J AAPOS. 2018;22:239–240.
  • Vidal JE. HIV-related cerebral toxoplasmosis revisited: current concepts and controversies of an old disease. J Int Assoc Provid AIDS Care. 2019;18:2325958219867315.
  • Robert-Gangneux F, Meroni V, Dupont D, et al. Toxoplasmosis in transplant recipients, Europe, 2010–2014. Emerg Infect Dis. 2018;24:1497–1504.
  • Robert-Gangneux F, Belaz S. Molecular diagnosis of toxoplasmosis in immunocompromised patients. Curr Opin Infect Dis. 2016;29:330–339.
  • Parmley SF, Goebel FD, Remington JS. Detection of Toxoplasma gondii in cerebrospinal fluid from AIDS patients by polymerase chain reaction. J Clin Microbiol. 1992;30:3000–3002.
  • Schoondermark-van de Ven E, Galama J, Kraaijeveld C, et al. Value of the polymerase chain reaction for the detection of Toxoplasma gondii in cerebrospinal fluid from patients with AIDS. Clin Infect Dis. 1993;16:661–666.
  • Novati R, Castagna A, Morsica G, et al. Polymerase chain reaction for Toxoplasma gondii DNA in the cerebrospinal fluid of AIDS patients with focal brain lesions. AIDS. 1994;8:1691–1694.
  • Khalifa KE-S, Roth A, Roth B, et al. Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis. J Clin Microbiol. 1994;32:2813–2819.
  • Dupon M, Cazenave J, Pellegrin JL, et al. Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients. J Clin Microbiol. 1995;33:2421–2426.
  • Eggers C, Groß U, Klinker H, et al. Limited value of cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis associated with AIDS. J Neurol. 1995;242:644–649.
  • Cingolani A, De Luca A, Ammassari A, et al. PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions. J Med Microbiol. 1996;45:472–476.
  • Vidal JE, Colombo FA, de Oliveira ACP, et al. PCR assay using cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients. J Clin Microbiol. 2004;42:4765–4768.
  • Nogui FLN, Mattas S, Turcato Júnior G, et al. Neurotoxoplasmosis diagnosis for HIV-1 patients by real-time PCR of cerebrospinal fluid. Braz J Infect Dis. 2009;13:18–23.
  • Correia CC, Melo HRL, Costa VMA. Influence of neurotoxoplasmosis characteristics on real-time PCR sensitivity among AIDS patients in Brazil. Trans R Soc Trop Med Hyg. 2010;104:24–28.
  • Alfonso Y, Fraga J, Cox R, et al. Conventional polymerase chain reaction for the diagnosis of neurotoxoplasmosis: comparison of three sets of primers for the B1 gene using CSF samples. Diagn Microbiol Infect Dis. 2013;75:150–154.
  • Mikita K, Maeda T, Ono T, et al. The utility of cerebrospinal fluid for the molecular diagnosis of toxoplasmic encephalitis. Diagn Microbiol Infect Dis. 2013;75:155–159.
  • Sakamoto N. Clinical presentation and diagnosis of toxoplasmic encephalitis in Japan. Parasitol Int. 2014;63:701–704.
  • Anselmo L, Vilar F, Lima J, et al. Usefulness and limitations of polymerase chain reaction in the etiologic diagnosis of neurotoxoplasmosis in immunocompromised patients. J Neurol Sci. 2014;346:231–234.
  • Dard C, Marty P, Brenier-Pinchart M-P, et al. Management of toxoplasmosis in transplant recipients: an update. Expert Rev Anti Infect Ther. 2018;16:447–460.
  • Hakko E, Ozkan HA, Karaman K, et al. Analysis of cerebral toxoplasmosis in a series of 170 allogeneic hematopoietic stem cell transplant patients. Transpl Infect Dis. 2013;15:575–580.
  • Dupouy-Camet J, de Souza SL, Maslo C, et al. Detection of Toxoplasma gondii in venous blood from AIDS patients by polymerase chain reaction. J Clin Microbiol. 1993;31:1866–1869.
  • Lamoril J, Molina JM, De Gouvello A, et al. Detection by PCR of Toxoplasma gondii in blood in the diagnosis of cerebral toxoplasmosis in patients with AIDS. J Clin Pathol. 1996;49:89–92.
  • Franzen C, Altfeld M, Hegener P, et al. Limited value of PCR for detection of Toxoplasma gondii in blood from human immunodeficiency virus-infected patients. J Clin Microbiol. 1997;35:2639–2641.
  • Colombo FA, Vidal JE, de Oliveira ACP, et al. Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples. J Clin Microbiol. 2005;43:5044–5047.
  • Cardona N, Basto N, Parra B, et al. Detection of Toxoplasma DNA in the peripheral blood of HIV-positive patients with neuro-opportunistic infections by a real-time PCR ASsay. J Neuroparasitolog. 2011;2:1–6.
  • Ajzenberg D, Lamaury I, Demar M, et al. Performance testing of PCR assay in blood samples for the diagnosis of toxoplasmic encephalitis in AIDS patients from the French Departments of America and genetic diversity of Toxoplasma gondii: a prospective and multicentric study. PLoS Negl Trop Dis. 2016;10(6):e0004790. .
  • Ajzenberg D. Is PCR testing on blood samples useful or not in the diagnosis of Toxoplasma encephalitis? Trans R Soc Trop Med Hyg. 2010;104:569–570.
  • Botterel F, Ichai P, Feray C, et al. Disseminated toxoplasmosis, resulting from infection of allograft, after orthotopic liver transplantation: usefulness of quantitative PCR. J Clin Microbiol. 2002;40:1648–1650.
  • Zimmermann S, Hadaschik E, Dalpke A, et al. Varicella-Like cutaneous toxoplasmosis in a patient with aplastic anemia. J Clin Microbiol. 2013;51:1341–1344.
  • Desoubeaux G, É C, Franck-Martel C, et al. Pulmonary toxoplasmosis in immunocompromised patients with interstitial pneumonia: a single-centre prospective study assessing PCR-based diagnosis. J Clin Pathol. 2016;69:726–730.
  • Bretagne S, Costa J-M, Foulet F, et al. Prospective study of Toxoplasma reactivation by polymerase chain reaction in allogeneic stem‐cell transplant recipients. Transpl Infect Dis. 2000;2:127–132.
  • Martino R, Bretagne S, Einsele H, et al. Early Detection of Toxoplasma Infection by Molecular Monitoring of Toxoplasma gondii in Peripheral Blood Samples after Allogeneic Stem Cell Transplantation. Clin Infect Dis. 2005;40:67–78.
  • Edvinsson B, Lundquist J, Ljungman P, et al. A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation. APMIS. 2008;116:345–351.
  • Fricker-Hidalgo H, Bulabois C-E, Brenier-Pinchart M-P, et al. Diagnosis of Toxoplasmosis after Allogeneic Stem Cell Transplantation: results of DNA Detection and Serological Techniques. Clin Infect Dis. 2009;48:e9–e15.
  • Derouin F, Pelloux H. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 2008;14:1089–1101.
  • Gajurel K, Dhakal R, Montoya JG. Toxoplasma prophylaxis in haematopoietic cell transplant recipients: a review of the literature and recommendations. Curr Opin Infect Dis. 2015;28(4):283–292.
  • Robert-Gangneux F, Sterkers Y, Yera H, et al. Molecular Diagnosis of Toxoplasmosis in Immunocompromised Patients: a 3-Year Multicenter Retrospective Study. J Clin Microbiol. 2015;53:1677–1684.
  • Holland GN. Ocular toxoplasmosis: a global reassessment. Am J Ophthalmol. 2003;136:973–988.
  • Holland GN. Ocular toxoplasmosis: a 50th Anniversary Tribute to the Contributions of Helenor Campbell Wilder Foerster. Arch Ophthalmol. 2002;120:1081–1084.
  • Garweg JG, de Groot-Mijnes JDF, Montoya JG. Diagnostic approach to ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19:255–261.
  • Greigert V, Foggia ED, Filisetti D, et al. When biology supports clinical diagnosis: review of techniques to diagnose ocular toxoplasmosis. Br J Ophthalmol. 2019;103:1008–1012.
  • Bourdin C, Busse A, Kouamou E, et al. PCR-based detection of Toxoplasma gondii DNA in blood and ocular samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol. 2014;52:3987–3991.
  • Greigert V, Pfaff AW, Sauer A, et al. Biological diagnosis of ocular toxoplasmosis: a nine-year retrospective observational study. mSphere. 2019;4:e00636–19.
  • Fekkar A, Bodaghi B, Touafek F, et al. Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient, and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol. 2008;46:1965–1967.
  • Talabani H, Asseraf M, Yera H, et al. Contributions of immunoblotting, real-time PCR, and the Goldmann-Witmer coefficient to diagnosis of atypical toxoplasmic retinochoroiditis. J Clin Microbiol. 2009;47:2131–2135.
  • Bou GN, Figueroa MS, Marti-Belda P, et al. Value of PCR for detection of Toxoplasma gondii in aqueous humor and blood samples from immunocompetent patients with ocular toxoplasmosis. J Clin Microbiol. 1999;37:3465–3468.
  • Contini C, Seraceni S, Cultrera R, et al. Evaluation of a Real-time PCR-based assay using the lightcycler system for detection of Toxoplasma gondii bradyzoite genes in blood specimens from patients with toxoplasmic retinochoroiditis. Int J Parasitol. 2005;35:275–283.
  • De Salvador-Guillouët F, Ajzenberg D, Chaillou-Opitz S, et al. Severe pneumonia during primary infection with an atypical strain of Toxoplasma gondii in an immunocompetent young man. J Infect. 2006;53:e47–e50.
  • Bossi P, Paris L, Caumes E, et al. Severe acute disseminated toxoplasmosis acquired by an Immunocompetent patient in French Guiana. Scand J Infect Dis. 2002;34:311–314.
  • Henao-Martínez AF, Franco-Paredes C, Palestine AG, et al. Symptomatic acute toxoplasmosis in returning travelers. Open Forum Infect Dis. 2018;5:1–3.
  • Sobanski V, Ajzenberg D, Delhaes L, et al. Severe toxoplasmosis in immunocompetent hosts: be aware of atypical strains. Am J Respir Crit Care Med. 2013;187:1143–1145.
  • Demar M, Hommel D, Djossou F, et al. Acute toxoplasmoses in immunocompetent patients hospitalized in an intensive care unit in French Guiana. Clin Microbiol Infect. 2012;18:E221–E231.
  • Leal FE, Cavazzana CL, de Andrade HF, et al. Toxoplasma gondii pneumonia in immunocompetent subjects: case report and review. Clin Infect Dis. 2007;44:e62–e66.
  • Lévêque MF, Chiffré D, Galtier C, et al. Molecular diagnosis of toxoplasmosis at the onset of symptomatic primary infection: a straightforward alternative to serological examinations. Int J Infect Dis. 2019;79:131–133.
  • Pustorino G, Ferlazzo E, Carpentieri MS, et al. Cerebral toxoplasmosis diagnosed by brain tissue PCR analysis in an immunocompetent patient. Neurol Clin Pract. 2017;7:436–438.
  • Brenier-Pinchart M-P, Varlet-Marie E, Robert-Gangneux F, et al. Impact of pre-analytic step duration on molecular diagnosis of toxoplasmosis for five types of biological samples. PLoS One. 2021;16(2):e0246802. .
  • Roux G, Varlet-Marie E, Bastien P, et al. Evolution of Toxoplasma-PCR methods and practices: a French national survey and proposal for technical guidelines. Int J Parasitol. 2018;48:701–707.
  • Menotti J, Garin YJ-F, Thulliez P, et al. Evaluation of a new 5ʹ-nuclease real-time PCR assay targeting the Toxoplasma gondii AF146527 genomic repeat. Clin Microbiol Infect. 2010;16:363–368.
  • Cassaing S, Bessières MH, Berry A, et al. Comparison between two amplification sets for molecular diagnosis of toxoplasmosis by real-time PCR. J Clin Microbiol. 2006;44:720–724.
  • Reischl U, Bretagne S, Krüger D, et al. Comparison of two DNA targets for the diagnosis of Toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes. BMC Infect Dis. 2003;3:7.
  • Kasper DC, Sadeghi K, Prusa A-R, et al. Quantitative real-time polymerase chain reaction for the accurate detection of Toxoplasma gondii in amniotic fluid. Diagn Microbiol Infect Dis. 2009;63:10–15.
  • Belaz S, Gangneux J-P, Dupretz P, et al. A 10-year retrospective comparison of two target sequences, REP-529 and B1, for Toxoplasma gondii detection by quantitative PCR. J Clin Microbiol. 2015;53:1294–1300.
  • Delhaes L, Yera H, Ache S, et al. Contribution of molecular diagnosis to congenital toxoplasmosis. Diagn Microbiol Infect Dis. 2013;76:244–247.
  • Roux G, Ravel C, Varlet-Marie E, et al. Inhibition of polymerase chain reaction: pathogen-specific controls are better than human gene amplification. PLos One. 2019;14:e0219276.
  • Menotti J, Vilela G, Romand S, et al. Comparison of PCR-enzyme-linked immunosorbent assay and real-time PCR assay for diagnosis of an unusual case of cerebral toxoplasmosis in a stem cell transplant recipient. J Clin Microbiol. 2003;41:5313–5316.
  • Varlet-Marie E, Sterkers Y, Perrotte M, et al. A new LAMP-based assay for the molecular diagnosis of toxoplasmosis: comparison with a proficient PCR assay. Int J Parasitol. 2018;48:457–462.
  • Brenier-Pinchart M-P, Capderou E, Bertini R-L, et al. Molecular diagnosis of toxoplasmosis: value of the buffy coat for the detection of circulating Toxoplasma gondii. Diagn Microbiol Infect Dis. 2015;82:289–291.
  • Tomasoni LR, Meroni V, Bonfanti C, et al. Multidisciplinary approach to congenital Toxoplasma infection: an Italian nationwide survey. New Microbiol. 2014;37:347–354.
  • Yera H, Filisetti D, Bastien P, et al. Multicenter comparative evaluation of five commercial methods for Toxoplasma DNA extraction from amniotic fluid. J Clin Microbiol. 2009;47:3881–3886.
  • Zhao F, Bulin L, Fricker-Hidalgo H, et al. Molecular diagnosis of toxoplasmosis: evaluation of automated DNA extraction using eMAG® (bioMérieux) on buffy coat, cerebrospinal and bronchoalveolar lavage fluids. Clin Chem Lab Med. 2020;58:e91–e93.
  • Faucher B, Miermont F, Ranque S, et al. Optimization of Toxoplasma gondii DNA extraction from amniotic fluid using NucliSENS easyMAG and comparison with QIAamp DNA minikit. Eur J Clin Microbiol Infect Dis. 2012;31:1035–1039.
  • Burg JL, Perelman D, Kasper LH, et al. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J Immunol. 1988;141:3584–3591.
  • Cazenave J, Cheyrou A, Blouin P, et al. Use of polymerase chain reaction to detect Toxoplasma. J Clin Pathol. 1991;44:1037.
  • Homan WL, Vercammen M, De Braekeleer J, et al. Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Int J Parasitol. 2000;30:69–75.
  • Cristina N, Derouin F, Pelloux H, et al. [Detection of Toxoplasma gondii by “Polymerase Chain Reaction” (PCR) technique in AIDS infected patients using the repetitive sequence TGR1E]. Pathol Biol. 1992;40:52–55.
  • Costa JM, Dardé ML, Assouline B, et al. Microsatellite in the beta-tubulin gene of Toxoplasma gondii as a new genetic marker for use in direct screening of amniotic fluids. J Clin Microbiol. 1997;35:2542–2545.
  • Feng XC, Milhausen M. Localization of Toxoplasma gondii in feline intestinal tissue using PCR. J Parasitol. 1999;85:1041–1046.
  • Bretagne S, Costa JM, Vidaud M, et al. Detection of Toxoplasma gondii by competitive DNA amplification of bronchoalveolar lavage samples. J Infect Dis. 1993;168:1585–1588.
  • Lin M-H, Chen T-C, Kuo T, et al. Real-time PCR for quantitative detection of Toxoplasma gondii. J Clin Microbiol. 2000;38:4121–4125.
  • Jalal S, Nord CE, Lappalainen M, et al. Rapid and sensitive diagnosis of Toxoplasma gondii infections by PCR. Clin Microbiol Infect. 2004;10:937–939.
  • Pelloux H, Weiss J, Simon J, et al. A new set of primers for the detection of Toxoplasma gondii in amniotic fluid using polymerase chain reaction. FEMS Microbiol Lett. 1996;138:11–15.
  • Sterkers Y, Varlet-Marie E, Marty P, et al. Diversity and evolution of methods and practices for the molecular diagnosis of congenital toxoplasmosis in France: a 4-year survey. Clin Microbiol Infect. 2010;16:1594–1602.
  • Wahab T, Edvinsson B, Palm D, et al. Comparison of the AF146527 and B1 repeated elements, two real-time PCR targets used for detection of Toxoplasma gondii. J Clin Microbiol. 2010;48:591–592.
  • Sterkers Y, Varlet-Marie E, Cassaing S, et al. Multicentric comparative analytical performance study for molecular detection of low amounts of Toxoplasma gondii from simulated specimens. J Clin Microbiol. 2010;48:3216–3222.
  • Okay TS, Yamamoto L, Oliveira LC, et al. Significant performance variation among PCR systems in diagnosing congenital toxoplasmosis in São Paulo, Brazil: analysis of 467 amniotic fluid samples. Clinics. 2009;64:171–176.
  • Camilo LM, Pereira-Chioccola VL, Gava R, et al. Molecular diagnosis of symptomatic toxoplasmosis: a 9-year retrospective and prospective study in a referral laboratory in São Paulo, Brazil. Braz J Infect Dis. 2017;21:638–647.
  • Pomares C, Estran R, Press CJ, et al. Is real-time PCR targeting rep 529 suitable for diagnosis of toxoplasmosis in patients infected with non-type II Strains in North America? J Clin Microbiol. 2020;58:e01223–19.
  • Maubon D, M-p B-P, Fricker-Hidalgo H, et al. Apport de la PCR quantitative dans le diagnostic de la toxoplasmose: la voie de la standardisation? [Real-time PCR in the diagnosis of toxoplasmosis: the way to standardisation?]. Pathol Biol. 2007;55:304–311.
  • Kralik P, Ricchi M. A basic guide to real time PCR in microbial diagnostics: definitions, parameters, and everything. Front Microbiol. 2017;8:108.
  • Nagy B, Bán Z, Beke A, et al. Detection of Toxoplasma gondii from amniotic fluid, a comparison of four different molecular biological methods. Clin Chim Acta. 2006;368:131–137.
  • Torres E, Rivera R, Cardona N, et al. Evaluation of IgG anti-Toxoplasma avidity and polymerase chain reaction in the postnatal diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J. 2013;32:693–695.
  • Morelle C, Varlet-Marie E, Brenier-Pinchart M-P, et al. Comparative assessment of a commercial kit and two laboratory-developed PCR assays for molecular diagnosis of congenital toxoplasmosis. J Clin Microbiol. 2012;50:3977–3982.
  • Bastien P, Procop GW, Reischl U. Quantitative real-time PCR is not more sensitive than “Conventional” PCR. J Clin Microbiol. 2008;46:1897–1900.
  • Varlet-Marie E, Sterkers Y, Brenier-Pinchart M-P, et al. Characterization and multicentric validation of a common standard for Toxoplasma gondii detection using nucleic acid amplification assays. J Clin Microbiol. 2014;52:3952–3959.
  • Notomi T, Mori Y, Tomita N, et al. Loop-mediated isothermal amplification (LAMP): principle, features, and future prospects. J Microbiol. 2015;53:1–5.
  • Sotiriadou I, Karanis P. Evaluation of loop-mediated isothermal amplification for detection of Toxoplasma gondii in water samples and comparative findings by polymerase chain reaction and immunofluorescence test (IFT). Diagn Microbiol Infect Dis. 2008;62:357–365.
  • Zhang H, Thekisoe OMM, Aboge GO, et al. Toxoplasma gondii: sensitive and rapid detection of infection by loop-mediated isothermal amplification (LAMP) method. Exp Parasitol. 2009;122:47–50.
  • Krasteva D, Toubiana M, Hartati S, et al. Development of loop-mediated isothermal amplification (LAMP) as a diagnostic tool of toxoplasmosis. Vet Parasitol. 2009;162:327–331.
  • Lau YL, Meganathan P, Sonaimuthu P, et al. Specific, Sensitive, and Rapid Diagnosis of Active Toxoplasmosis by a Loop-Mediated Isothermal Amplification Method Using Blood Samples from Patients. J Clin Microbiol. 2010;48:3698–3702.
  • Fallahi S, Seyyed Tabaei SJ, Pournia Y, et al. Comparison of loop-mediated isothermal amplification (LAMP) and nested-PCR assay targeting the RE and B1 gene for detection of Toxoplasma gondii in blood samples of children with leukaemia. Diagn Microbiol Infect Dis. 2014;79:347–354.
  • Sun X, Ji Y, Liu X, et al. Improvement and evaluation of loop-mediated isothermal amplification for rapid detection of Toxoplasma gondii infection in human blood samples. PLos One. 2017;12:e0169125.
  • Soltani Tehrani B, Mirzajani E, Fallahi S, et al. Challenging TaqMan probe-based real-time PCR and loop-mediated isothermal amplification (LAMP): the two sensitive molecular techniques for the detection of toxoplasmosis, a potentially dangerous opportunistic infection in immunocompromised patients. Arch Microbiol. 2020;202:1881–1888.
  • Robert-Gangneux F, Brenier-Pinchart M-P, Yera H, et al. Evaluation of Toxoplasma ELITe MGB real-time PCR assay for diagnosis of Toxoplasmosis. J Clin Microbiol. 2017;55:1369–1376.
  • Filisetti D, Sterkers Y, Brenier-Pinchart M-P, et al. Multicentric comparative assessment of the bio-evolution Toxoplasma gondii detection kit with eight laboratory-developed PCR assays for molecular diagnosis of congenital toxoplasmosis. J Clin Microbiol. 2015;53:29–34.
  • Ammar NA, Yera H, Bigot J, et al. Multicentric evaluation of the bio-evolution Toxoplasma gondii assay for the detection of Toxoplasma DNA in Immunocompromised patients. J Clin Microbiol. 2019;58:e01231.
  • Döşkaya M, Pullukçu H, Karakavuk M, et al. Comparison of an in house and a commercial real-time polymerase chain reaction targeting Toxoplasma gondii RE gene using various samples collected from patients in Turkey. BMC Infect Dis. 2019;19:1042.
  • Su C, Shwab EK, Zhou P, et al. Moving towards an integrated approach to molecular detection and identification of Toxoplasma gondii. Parasitology. 2010;137:1–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.